Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CCR2 | P41597 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17099143 | 1.00 | HSD11B1 (0.33) | HSD11B1TSHRMAPK1CCR2KCNH2 | |
| SCHEMBL17098507 | 0.90 | HSD11B1 (0.33) | HSD11B1TSHRMAPK1CCR2KCNH2 | |
| SCHEMBL17098505 | 0.90 | HSD11B1 (0.33) | HSD11B1TSHRMAPK1CCR2KCNH2 | |
| SCHEMBL17097937 | 0.90 | TSHR (0.35) | HSD11B1TSHRMAPK1CCR2KCNH2 | |
| SCHEMBL17097934 | 0.90 | TSHR (0.35) | HSD11B1TSHRMAPK1CCR2KCNH2 | |
| SCHEMBL17098279 | 0.88 | HSD11B1 (0.32) | HSD11B1TSHRMAPK1CCR2KCNH2 | |
| SCHEMBL17098275 | 0.88 | HSD11B1 (0.32) | HSD11B1TSHRMAPK1CCR2KCNH2 | |
| SCHEMBL17097638 | 0.88 | POLB (0.34) | HSD11B1TSHRMAPK1CCR2KCNH2 | |
| SCHEMBL17097642 | 0.88 | POLB (0.34) | HSD11B1TSHRMAPK1CCR2KCNH2 | |
| SCHEMBL17098995 | 0.87 | CYP2C19 (0.34) | HSD11B1TSHRMAPK1CCR2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9365522-B2 | Pyrazole amide derivative | AMGEN INC. (US) | 2016-06-14 | — | — | US | disclosed |
| US-20150266824-A1 | Pyrazole Amide Derivative | TEIJIN LIMITED (JP) | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150266824-A1 | Pyrazole Amide Derivative | RORC, RORB, RORA | HSD11B1 195/4885TSHR 873/4885MAPK1 2696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.